Nutritional Regulation of Bile Acid Metabolism is Associated with Improved Pathological Characteristics of the Metabolic Syndrome
Bjorn Liaset,Qin Hao,Henry Jorgensen,Philip Hallenborg,Zhen-Yu Du,Tao Ma,Hanns-Ulrich Marschall,Mogens Kruhoffer,Ruiqiang Li,Qibin Li,Christian Clement Yde,Gabriel Criales,Hanne C. Bertram,Gunnar Mellgren,Erik Snorre Ofjord,Erik-Jan Lock,Marit Espe,Livar Froyland,Lise Madsen,Karsten Kristiansen
DOI: https://doi.org/10.1074/jbc.m111.234732
IF: 5.485
2011-01-01
Journal of Biological Chemistry
Abstract:Bile acids (BAs) are powerful regulators of metabolism, and mice treated orally with cholic acid are protected from diet-induced obesity, hepatic lipid accumulation, and increased plasma triacylglycerol (TAG) and glucose levels. Here, we show that plasma BA concentration in rats was elevated by exchanging the dietary protein source from casein to salmon protein hydrolysate (SPH). Importantly, the SPH-treated rats were resistant to diet-induced obesity. SPH-treated rats had reduced fed state plasma glucose and TAG levels and lower TAG in liver. The elevated plasma BA concentration was associated with induction of genes involved in energy metabolism and uncoupling, Dio2, Pgc-1α, and Ucp1, in interscapular brown adipose tissue. Interestingly, the same transcriptional pattern was found in white adipose tissue depots of both abdominal and subcutaneous origin. Accordingly, rats fed SPH-based diet exhibited increased whole body energy expenditure and heat dissipation. In skeletal muscle, expressions of the peroxisome proliferator-activated receptor β/δ target genes (Cpt-1b, Angptl4, Adrp, and Ucp3) were induced. Pharmacological removal of BAs by inclusion of 0.5 weight % cholestyramine to the high fat SPH diet attenuated the reduction in abdominal obesity, the reduction in liver TAG, and the decrease in nonfasted plasma TAG and glucose levels. Induction of Ucp3 gene expression in muscle by SPH treatment was completely abolished by cholestyramine inclusion. Taken together, our data provide evidence that bile acid metabolism can be modulated by diet and that such modulation may prevent/ameliorate the characteristic features of the metabolic syndrome.